← SynDRA
SUCCINOBUCOL
SynDRA canonical compound SYN0003466 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
|---|
| Primary target(s) | CCL2 | MAPK1 | MAPK11 | MAPK3 | VCAM1 |
|---|
| Mechanism of action | antioxidant |
|---|
All known targets
- CCL2
- MAPK1
- MAPK11
- MAPK3
- VCAM1
Mechanisms of action (all sources)
Cross-references
Synonyms
- AGI-1067
- AGZ-1067
- Succinic acid 2,6-di-tert-butyl-4-[1-(3,5-di-tert-butyl-4-hydroxyphenylsulfanyl)-1-methylethylsulfanyl]phenyl monoester
- J1J54V24R4
- succinobucolum
- RefChem:186353
- DTXCID3098494
- AGI-1067;Probucol monosuccinate
- C35H52O5S2
- Succinobucol (USAN)
- Probucol Monosuccinate
- SUCCINOBUCOL [USAN]
- Probucol monosuccinae
- MFCD08690469
- SUCCINOBUCOL [MI]
- SUCCINOBUCOL [INN]
- Succinobucol [USAN:INN]
- SuccinobucolAGI 1067)?
- Succinobucol (AGI 1067)
- SCHEMBL347492
- UNII-J1J54V24R4
- orb1302985
- AGI1067
- CHEBI:177810
- GLXC-05769
- HMS3746A21
- HMS6019L04
- EX-A5058
- AGI 10674
- BDBM50117525
- NSC810340
- s6420
- SC5126
- AKOS030254650
- CS-7896
- FS27918
- NSC-810340
- AC-36902
- BS-16625
Look up SUCCINOBUCOL in the interactive SynDRA portal →